Niagen Bioscience, Inc. (FRA:OCD1)
5.70
+0.10 (1.79%)
At close: Nov 28, 2025
Niagen Bioscience Employees
Niagen Bioscience had 104 employees as of December 31, 2024. The number of employees decreased by 2 or -1.89% compared to the previous year.
Employees
104
Change (1Y)
-2
Growth (1Y)
-1.89%
Revenue / Employee
€1,022,014
Profits / Employee
€167,420
Market Cap
459.51M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 104 | -2 | -1.89% |
| Dec 31, 2023 | 106 | -7 | -6.19% |
| Dec 31, 2022 | 113 | -2 | -1.74% |
| Dec 31, 2021 | 115 | 5 | 4.55% |
| Dec 31, 2020 | 110 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 2, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 318,000 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 103,000 |
| Deutsche Bank Aktiengesellschaft | 89,753 |